Clinical trials

  • ADAGRASIB for Advanced non-small cell lung cancer
  • MB097 for Advanced melanoma|Malignant melanoma
  • (S)-4,5-DIHYDRO-2-[2-HYDROXY-4-(3,6-DIOXAHEPTYLOXY)PHENYL]-4-METHYL-4-THIAZOLECARBOXYLIC ACID for Transfusion-dependent alpha thalassemia | Transfusion-dependent beta thalassemia | Low-risk myelodysplastic syndromes
  • Rezpegaldesleukin for Atopic dermatitis
  • TRETINOIN for Acute myeloid leukemia
  • RALUDOTATUG DERUXTECAN for Small cell lung cancer (extensive-stage)
  • Conditioned medium from a co-culture of M2-macrophages and fat-derived mesenchymal cells for Acute respiratory distress syndrome (ARDS) | SARS-CoV-2 infection | Influenza A infection | Influenza B infection | Respiratory syncytial virus (RSV) infection
  • PIRTOBRUTINIB for Chronic lymphocytic leukemia | Small lymphocytic lymphoma
  • RUXOLITINIB for Chronic graft-versus-host disease (steroid-refractory)
  • Pancreas powder (pancreatin) for Pancreatic exocrine insufficiency
  • Luspatercept for Myelofibrosis | Anemia associated with myeloproliferative neoplasm-associated myelofibrosis
  • TULMIMETOSTAT for Advanced solid tumors | Lymphoma | Urothelial carcinoma | Ovarian clear cell carcinoma | Endometrial carcinoma | Peripheral T-cell lymphoma | Diffuse large B-cell lymphoma | Malignant pleural mesothelioma | Peritoneal mesothelioma | Metastatic castration-resistant prostate cancer